Performance of a biological deoxygenation process for ships' ballast water treatment under very cold water conditions

Water deoxygenation is listed among the promising on-board treatment technologies to treat ships' ballast waters to reduce the risk of species transfer. We assessed the performance of a yeast-based bioreactive deoxygenation process in very cold water (<2°C) and determined the potential toxicity of the residual treated waters. Experiments using two treatment levels (0.5% and 1% v/v) were conducted in large-volume (4.5m(3)) tanks over 19 days at mean temperature of 1.5°C. Time to hypoxia varied between 10.3 and 16 days, being slightly higher than the predicted time of 9.8 days from previous empirical relationships. Water deoxygenation was achieved when yeast density exceeded 5×10(5) viable cellsmL(-1) and variation in time to hypoxia was mainly explained by difference in yeast growth. There was no oxycline and no significant difference in yeast density over the 2-m deep water column. Results from six bioassays indicated weak toxic response of treated waters at the 1.0% level, but no potential toxic response at the 0.5% treatment level. Results confirmed that the potential application of a yeast-based deoxygenation process for treating ships' ballast waters extended over the range of water temperature typically encountered during most shipping operational conditions. Time to reach full deoxygenation may however be limiting for universal application of this treatment which should be preferably used for ships making longer voyages in cold environments. There was no evidence that biological deoxygenation at low temperature did increase toxicity risk of treated waters to impede their disposal at the time of discharge.